CURAXIS PHARMACEUTICAL Corp (CURX.PK) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 23 transactions totaling $415.5K, demonstrating a bearish sentiment with -$355.5K in net insider flow. The most recent transaction on Jan 19, 2012 involved a transaction of 150,000 shares valued at $6.0K.
No significant insider buying has been recorded for CURX.PK in the recent period.
No significant insider selling has been recorded for CURX.PK in the recent period.
Based on recent SEC filings, insider sentiment for CURX.PK is bearish with an Insider Alignment Score of 7/100 and a net flow of -$355.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CURAXIS PHARMACEUTICAL Corp (CURX.PK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading CURX.PK stock, having executed 23 transactions in the past 90 days. The most active insider is Patrick S. Smith (Executive), who has made 8 transactions totaling $385.5K.
Get notified when executives and directors at CURX.PK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 19, 2012 | Ivan F. Gothner K. | Executive | Award | 150,000 | $0.04 | $6.0K | |
| Jan 19, 2012 | Novak Terence | Executive | Award | 150,000 | $0.04 | $6.0K | |
| Jan 19, 2012 | W. George Michael | Executive | Award | 200,000 | $0.04 | $8.0K | |
| Jan 19, 2012 | J. Leary Stephen | Executive | Award | 200,000 | $0.04 | $8.0K | |
| Nov 17, 2011 | Ivan F. Gothner K. | Executive | Award | 70,671 | $0.08 | $5.7K | |
| Nov 17, 2011 | Novak Terence | Executive | Award | 70,671 | $0.08 | $5.7K | |
| Nov 17, 2011 | W. George Michael | Executive | Award | 94,229 | $0.08 | $7.5K | |
| Nov 17, 2011 | J. Leary Stephen | Executive | Award | 39,229 | $0.08 | $3.1K | |
| Nov 17, 2011 | J. Leary Stephen | Executive | Award | 55,000 | $0.08 | $4.4K | |
| Nov 2, 2011 | S. Smith Patrick | Executive | Sale | 1,650,000 | $0.05 | $82.5K | |
| Oct 11, 2011 | S. Smith Patrick | Executive | Sale | 820,000 | $0.05 | $41.0K | |
| Oct 10, 2011 | W. George Michael | Executive | Purchase | 100,000 | $0.05 | $5.0K | |
| Oct 10, 2011 | S. Smith Patrick | Executive | Gift | 25,000 | $N/A | $0 | |
| Oct 10, 2011 | S.t. Geaslen Judith | Executive | Gift | 25,000 | $N/A | $0 | |
| Oct 3, 2011 | J. Leary Stephen | Executive | Purchase | 50,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 7 | $385.5K | 82.0% |
Award(A) | 9 | $54.4K | 11.6% |
Purchase(P) | 5 | $30.0K | 6.4% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at CURAXIS PHARMACEUTICAL Corp has increased, with 6 insiders executing 23 transactions across all time. Total sales of $385.5K significantly outpace purchases of $30.0K, resulting in a net outflow of $355.5K. This selling activity appears largely discretionary, which may warrant closer attention from investors.